Liquid suspension concentrate formulations containing saflufenacil
US8703650B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2010 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Jan 6, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01N43/54
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to liquid suspension concentrate formulations for plant protection comprising: 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide in the form of the crystalline anhydrate; at least one diluent selected from: hydrocarbon solvents having a boiling point of at least 100° C.; and C1-C8-alkyl esters of C8-C26-fatty acids, mono- and di-C1-C4-alkyl amides of C8-C26-fatty acids; at least two different non-ionic surfactants selected from poly-ethoxylate-co-C3-C4-alkoxylates of C3-C20-alkanols, polyethoxylates of C8-C22-alkanols, polyester-polyoxyethylene block copolymers, polyethoxylates of mono-, di- or tristyryl phenols and polyethoxylates of vegetable oils; and at least one anionic surfactant selected from C1-C16-alkylarene sulfonates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.